ACT Share Price Performance
R1.50
-1.10 (-42.31%)
Price R1.50
Share Pricen/a
The Market Doesn't Like What It Sees From AfroCentric Investment Corporation Limited's (JSE:ACT) Revenues Yet
Nov 05
AfroCentric Investment Corporation Limited Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 2 Fair Values set on narratives written by author
ACT Community Narratives
There are no narratives available yet.
There are no community narratives available.
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
AfroCentric Investment Corporation Limited Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- -0.016
- 45.43%
- -0.15%
- 19.6%
About ACT
- Founded
- 2008
- Employees
- n/a
- CEO
- WebsiteView website
AfroCentric Investment Corporation Limited, an investment holding company, provides healthcare administration and health risk management solutions to the healthcare sector. The company operates through Healthcare SA, Healthcare Retail, Healthcare Africa, and Information Technology segments. It offers HIV and other healthcare management solutions. The company engages in the retail and wholesale of pharmaceutical products under the Activo Health, AfroCentric Technologies, AfA, Allegra, Denis, EssentialMED, Klinikka, Medscheme, Pharmacy Direct, Scriptpharm, Tendahealth, Forrester Pharma, Pharmacy Direct, Curasana Wholesaler, The Cheese has Moved, and other brand names. AfroCentric Investment Corporation Limited operates in South Africa, Botswana, Mauritius, Namibia, and Eswatini. The company was founded in 2008 and is based in Roodepoort, South Africa. AfroCentric Investment Corporation Limited operates as a subsidiary of Sanlam Limited.
